242 related articles for article (PubMed ID: 34491467)
1. Diffusion-weighted imaging in prostate cancer.
Tamada T; Ueda Y; Ueno Y; Kojima Y; Kido A; Yamamoto A
MAGMA; 2022 Aug; 35(4):533-547. PubMed ID: 34491467
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1.
Tamada T; Kido A; Yamamoto A; Takeuchi M; Miyaji Y; Moriya T; Sone T
J Magn Reson Imaging; 2021 Jan; 53(1):283-291. PubMed ID: 32614123
[TBL] [Abstract][Full Text] [Related]
3. Head-to-head comparison of biparametric versus multiparametric MRI of the prostate before robot-assisted transperineal fusion prostate biopsy.
Thaiss WM; Moser S; Hepp T; Kruck S; Rausch S; Scharpf M; Nikolaou K; Stenzl A; Bedke J; Kaufmann S
World J Urol; 2022 Oct; 40(10):2431-2438. PubMed ID: 35922717
[TBL] [Abstract][Full Text] [Related]
4. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
[TBL] [Abstract][Full Text] [Related]
5. Investigating the equivalent performance of biparametric compared to multiparametric MRI in detection of clinically significant prostate cancer.
Wang B; Gao J; Zhang Q; Zhang C; Liu G; Wei W; Huang H; Fu Y; Li D; Zhang B; Guo H
Abdom Radiol (NY); 2020 Feb; 45(2):547-555. PubMed ID: 31907568
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer detection with biparametric magnetic resonance imaging (bpMRI) by readers with different experience: performance and comparison with multiparametric (mpMRI).
Gatti M; Faletti R; Calleris G; Giglio J; Berzovini C; Gentile F; Marra G; Misischi F; Molinaro L; Bergamasco L; Gontero P; Papotti M; Fonio P
Abdom Radiol (NY); 2019 May; 44(5):1883-1893. PubMed ID: 30788558
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice.
Zawaideh JP; Sala E; Shaida N; Koo B; Warren AY; Carmisciano L; Saeb-Parsy K; Gnanapragasam VJ; Kastner C; Barrett T
Eur Radiol; 2020 Jul; 30(7):4039-4049. PubMed ID: 32166495
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility artifacts and PIRADS 3 lesions in prostatic MRI: how often is the dynamic contrast-enhance sequence necessary?
Antunes N; Vas D; Sebastia C; Salvador R; Ribal MJ; Nicolau C
Abdom Radiol (NY); 2021 Jul; 46(7):3401-3409. PubMed ID: 33683430
[TBL] [Abstract][Full Text] [Related]
9. Synthetic magnetic resonance imaging for primary prostate cancer evaluation: Diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry measurements.
Arita Y; Akita H; Fujiwara H; Hashimoto M; Shigeta K; Kwee TC; Yoshida S; Kosaka T; Okuda S; Oya M; Jinzaki M
Eur J Radiol Open; 2022; 9():100403. PubMed ID: 35242886
[TBL] [Abstract][Full Text] [Related]
10. MRI combined with PSA density in detecting clinically significant prostate cancer in patients with PSA serum levels of 4∼10ng/mL: Biparametric versus multiparametric MRI.
Han C; Liu S; Qin XB; Ma S; Zhu LN; Wang XY
Diagn Interv Imaging; 2020 Apr; 101(4):235-244. PubMed ID: 32063483
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the compliance with minimum acceptable technical parameters proposed by PI-RADS v2 guidelines in multiparametric prostate MRI acquisition in tertiary referral hospitals in the Republic of Turkey.
Coşkun M; Sarp AF; Karasu Ş; Gelal MF; Türkbey B
Diagn Interv Radiol; 2019 Nov; 25(6):421-427. PubMed ID: 31650967
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a Deep Learning-Accelerated vs. Conventional T2-Weighted Sequence in Biparametric MRI of the Prostate.
Tong A; Bagga B; Petrocelli R; Smereka P; Vij A; Qian K; Grimm R; Kamen A; Keerthivasan MB; Nickel MD; von Busch H; Chandarana H
J Magn Reson Imaging; 2023 Oct; 58(4):1055-1064. PubMed ID: 36651358
[TBL] [Abstract][Full Text] [Related]
13. Investigating the role of DCE-MRI, over T2 and DWI, in accurate PI-RADS v2 assessment of clinically significant peripheral zone prostate lesions as defined at radical prostatectomy.
Taghipour M; Ziaei A; Alessandrino F; Hassanzadeh E; Harisinghani M; Vangel M; Tempany CM; Fennessy FM
Abdom Radiol (NY); 2019 Apr; 44(4):1520-1527. PubMed ID: 30361870
[TBL] [Abstract][Full Text] [Related]
14. Comparison of PI-RADS version 2 and PI-RADS version 2.1 for the detection of transition zone prostate cancer.
Tamada T; Kido A; Takeuchi M; Yamamoto A; Miyaji Y; Kanomata N; Sone T
Eur J Radiol; 2019 Dec; 121():108704. PubMed ID: 31669798
[TBL] [Abstract][Full Text] [Related]
15. Prebiopsy Biparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2: A Multicenter Study.
Choi MH; Kim CK; Lee YJ; Jung SE
AJR Am J Roentgenol; 2019 Apr; 212(4):839-846. PubMed ID: 30779662
[TBL] [Abstract][Full Text] [Related]
16. Benefit of dynamic contrast-enhanced (DCE) imaging for prostate cancer detection depending on readers experience in prostate MRI.
Ziayee F; Schimmöller L; Boschheidgen M; Kasprowski L; Al-Monajjed R; Quentin M; Radtke JP; Albers P; Antoch G; Ullrich T
Clin Radiol; 2024 Mar; 79(3):e468-e474. PubMed ID: 38185579
[TBL] [Abstract][Full Text] [Related]
17. Biparametric vs multiparametric prostate magnetic resonance imaging for the detection of prostate cancer in treatment-naïve patients: a diagnostic test accuracy systematic review and meta-analysis.
Alabousi M; Salameh JP; Gusenbauer K; Samoilov L; Jafri A; Yu H; Alabousi A
BJU Int; 2019 Aug; 124(2):209-220. PubMed ID: 30929292
[TBL] [Abstract][Full Text] [Related]
18. Prospective PI-RADS v2.1 Atypical Benign Prostatic Hyperplasia Nodules With Marked Restricted Diffusion: Detection of Clinically Significant Prostate Cancer on Multiparametric MRI.
Costa DN; Jia L; Subramanian N; Xi Y; Rofsky NM; Recchimuzzi DZ; de Leon AD; Arraj P; Pedrosa I
AJR Am J Roentgenol; 2021 Aug; 217(2):395-403. PubMed ID: 32876473
[No Abstract] [Full Text] [Related]
19. Deep-Learning Models for Detection and Localization of Visible Clinically Significant Prostate Cancer on Multi-Parametric MRI.
Sun Z; Wu P; Cui Y; Liu X; Wang K; Gao G; Wang H; Zhang X; Wang X
J Magn Reson Imaging; 2023 Oct; 58(4):1067-1081. PubMed ID: 36825823
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Prostate Cancer in PI-RADS Version 2.1 Transition Zone Atypical Nodules Upgraded by Abnormal DWI: Correlation With MRI-Directed TRUS-Guided Targeted Biopsy.
Lim CS; Abreu-Gomez J; Carrion I; Schieda N
AJR Am J Roentgenol; 2021 Mar; 216(3):683-690. PubMed ID: 32755208
[No Abstract] [Full Text] [Related]
[Next] [New Search]